Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
OMUFA Reauthorization: US FDA Would Identify Rx-OTC Switch Candidates, Work With Sponsors
Sep 30 2025
•
By
Kate Rawson
The bill provisions support a bipartisan interest in promoting more Rx to OTC switches.
(Shutterstock)
More from Post-Marketing Regulation & Studies
More from United States